This is normal as semaglutide GLP-1 works gradually to regulate appetite, slow gastric emptying, and improve insulin sensitivity
Kellogg Clinic stands out as a premier destination, offering cutting-edge solutions tailored to your unique needs
Ngo-Hamilton adds. They would understand how these drugs could potentially interact with other medications you are taking, and which makes more sense for your current lifestyle, recognizing that these medications are not interchangeable. Not all bodies are the same People will respond differently to both medications
Clinical research demonstrates that GLP-1 receptor agonists produce significant overall weight loss, which includes reductions in abdominal and visceral fat
1).29,32 With respect to the vascular system, rGLP-1 activation induces modest decreases in blood pressure,33,34 it has a vasodilator effect, improves arterial stiffness, and prevents atherosclerotic plaque formation-and has plaque stabilizing effects-through its anti-inflammatory and antiapoptotic effects as demonstrated in animal models.29,32,3538 Despite controversies about rGLP-1 expression in vascular smooth muscle and endothelial cells, studies have shown that arGLP-1 has antiproliferative effects on these cells,39 reduces oxidative stress, improves endothelial function, and increases nitric oxide production in experimental models.3540 In the heart they produce a discrete increase in heart rate (24 beats/min), although this does not seem to be associated with an increase in arrhythmias or cardiovascular events

I am going to see what else I can find about it as the code book has a reference to the AHA #4 I understand the concern for not wanting to mess up a patient's insurance coverage when using a drug off-label, but for coding purposes the patient is a long-term user of the non-insulin anti-diabetic medication regardless of whether or not they are actually diabetic